The State of Comprehensive Genomic Profiling at One of America’s Largest Health Systems with Carlo Bifulco

Carlo Bifulco, Chief Medical Officer at Providence Genomics

Bio and Contact Info

Chapters:

0:00 Only 1 out of 2 patients nationwide seeing benefits of genomic profiling in cancer

7:45 What is the state of the art at Providence?

14:18 Are pathologists on board?

20:22 Do patients come in knowing about CGP?

24:43 Where to from here?

Carlo Bifulco joins us today. He’s an Italian who helped persuade one of America’s largest not-for-profit health systems that providing more genomic information to cancer patients early on was the right thing. With 52 hospitals, over 1,000 physician clinics, more than 120,000 caregivers serving communities across seven states—Alaska, California, Montana, New Mexico, Oregon, Texas, and Washington—Providence and Carlo have quite a task ahead. We ask Carlo what is the state of comprehensive genomic profiling at Providence today?



Customize This

New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup